Analyst
Maxim Group
Equibles does not estimate personal net worth.
Jeremy Pearlman is recorded as Analyst at Maxim Group. Jeremy Pearlman has spoken on 16 earnings calls across 10 companies, most recently for JOINT Corp on November 5, 2026. Those appearances were for Rockwell Medical, Inc. (RMTI), electroCore, Inc. (ECOR), PAVmed Inc. (PAVM), Myomo, Inc. (MYO), Lucid Diagnostics Inc. (LUCD) and 5 other companies. The companies whose calls Jeremy Pearlman spoke on are classified in the Healthcare sector.
“Firstly, you mentioned that, you know, some of the newer franchise clinics are actually performing well. I mean, what do you think you attribute that to, and how do you replicate that to the current franchise base?”
“First, I want to talk about a little bit on the guide. It seems like in the last earnings release on the call, you had guided towards adjusted EBITDA 27 in the third quarter.”
“First, are you in touch with the physicians who are using the recalled 135-centimeter delivery system, and what's their take on the timeline, and are they going to be happy to reengage with the company and the Seaguard Prime once it's hopefully recleared?”
“I know it seems like commercialization is going well. Are there any metrics maybe you could provide, you know, how many patients have been onboarded, how quickly is the number growing, and then maybe what milestones investors should look forward to as they gauge, you know, the commercial traction of that platform?”
“First, a really thorough overview of the company and where it stands commercially.”
Maxim Group
Analyst
Source not stated
Drug Manufacturers - Specialty & Generic · Healthcare
ECOR
Medical Devices · Healthcare
PAVM
Medical Devices · Healthcare
MYO
Medical Devices · Healthcare
JYNT
Medical Care Facilities · Healthcare
NSPR
Medical Devices · Healthcare
BEAT
Health Information Services · Healthcare
NEPH
Medical Instruments & Supplies · Healthcare
